You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 12, September 22/29, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Breast Cancer
 •Women's Health
 •Women's Health, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Association of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Terry and colleagues recently demonstrated an association between aspirin use and a reduced incidence of hormone receptor–positive breast cancer.1 We are concerned about how the implied relative change of risk (a 26% decrease; OR, 0.74; 95% CI, 0.60-0.93) is presented to the public without addressing the absolute risk reduction.

To really understand what this statistic means, readers should know that 26% represents the decrease in the risk of breast cancer present in nonaspirin users. Given the study design (a population-based case-control study), the risk of breast cancer overall can be calculated: it is the total number of incident breast cancer cases (2030 originally identified in the Long Island Breast Cancer Study Project2), divided by the population at risk (1 021 348 women aged 20 years and older in Nassau and Suffolk counties, New York, US Census 1997). Based on the odds ratio and knowing the proportion of . . . [Full Text of this Article]

Steven Woloshin, MD, MS
steven.woloshin@dartmouth.edu

Lisa M. Schwartz, MD, MS
VA Outcomes Group
White River Junction, Vt



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Association of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk
Patricia G. Moorman
JAMA. 2004;292(12):1426.
EXTRACT | FULL TEXT  

Association of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk—Reply
Mary Beth Terry, Marilie Gammon, and Alfred I. Neugut
JAMA. 2004;292(12):1427.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.